Design and Synthesis of Peptides Passing through the Blood-Brain Barrier
スポンサーリンク
概要
- 論文の詳細を見る
- Chemical Society of Japanの論文
- 1998-03-15
著者
-
Tsuji Akira
金沢大学 自然科学研究科創剤科学
-
Kobayashi Hiroyuki
Department Of Pediatric Surgery Juntendo Univ
-
Tsuji A
金沢大学 自然科学研究科創剤科学
-
Sai Yoshimichi
Division Of Pharmaceutical Sciences Graduate School Of Natural Science & Technology
-
Sai Yoshimichi
Department Of Biochemistry Faculty Of Pharmaceutical Sciences Kanazawa University
-
Tamai I
Tokyo Univ. Sci. Tokyo Jpn
-
Tamai Ikumi
Meiji Seika Kaisha Ltd. Pharmaceutical Research Center:department Of Surgery Kawasaki City Ida Hospi
-
Tamai Ikumi
Department Of Membrane Transport And Pharmacokinetics Faculty Of Pharmacy Institute Of Medical Pharm
-
Tamai Ikumi
Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Kanazawa University
-
Tamai Ikumi
Department Of Membrane Transport And Pharmacokinetics Faculty Of Pharmaceutical Sciences Tokyo Unive
-
Tamai Ikumi
Faculty Of Pharmaceutical Sciences And Hospital Pharmacy Kanazawa University
-
Tsuji Akira
Department Of Pediatrics:hospital Pharmacy:and Faculty Of Pharmaceutical Sciences University Of Kana
-
KUSUMOTO Shoichi
Department of Chemistry, Graduate School of Science, Osaka University
-
WAKAMIYA Tateaki
Faculty of Science and Technology, Kinki University
-
WAKAMIYA Tateaki
Department of Chemistry, Faculty of Science, Osaka University
-
KAMATA Makoto
Department of Chemistry, Faculty of Science, Osaka University
-
Kamata Makoto
Department Of Chemistry Faculty Of Science Osaka University
-
Kusumoto Shoichi
Department Of Chemistry Faculty Of Science Osaka University
-
Tsuji Akira
Department Of Molecular Pharmaceutics Graduate School Of Natural Science And Technology Kanazawa Uni
-
Kobayashi Hiroyuki
Department Of Applied Chemistry Saitama University
-
Wakamiya T
Faculty Of Science And Technology Kinki University
-
Wakamiya Tateaki
Department Of Chemistry Faculty Of Science Osaka University
-
Sai Y
Division Of Pharmaceutical Sciences Graduate School Of Natural Science & Technology
-
Kobayashi Hiroyuki
Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Kanazawa University
-
Kobayashi Hiroyuki
Department Of Anesthesiology Okayama Red Cross Hospital
関連論文
- Age and Sex-Dependent Alterations in Heart Rate Variability : Profiling the Characteristics of Men and Women in Their 30s
- Simvastatin reduces myocardial infarct size via increased nitric oxide production in normocholesterolemic rabbits
- PJ-163 Oxytocin Treatment after Myocardial Infarction Promotes Cardiac Repair and Neovascularization through Activation of Multiple Pro-survival Signals(PJ028,Cardiovascular Pharmacology (Basic), Cost-health care system/DPC/Laws (H),Poster Session (Japane
- FRS-043 Voglibose Reduces Myocardial Infarct Size via Stimulation of GLP-1 Receptors and PI3 kinase-Akt-eNOS Pathway in Rabbits(FRS9,Novel Mechanisms of Myocardial Ischemia (IHD),Featured Research Session (English),The 73rd Annual Scientific Meeting of Th
- PJ-723 The Anti-Diabetic Drug Voglibose Reduces Myocardial Infarct Size and Improves Left Ventricular Function via Production of Glucagon-like Peptide-1 in Rabbits(Myocardial ischemia / reperfusion, basic / clinical(04)(IHD),Poster Session(Japanese),The 7
- PE-228 Migritol Improve Myocardial Ischemia in Type 2 Diabetic Patients with Coronary Artery Disease(Nuclear cardiology(04)(I),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OE-182 Oxytocin reduces myocardial infarct size and improves left ventricular function and remodeling through activation of Akt, VEGF, BCI-2 and Angiogenesis(Growth factor/Cytokine(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of th
- OE-070 Post-Infarct Treatment with an Erythropoietin-Gelatin Hydrogel Patchlmproves Cardiac Function by Activating Prosurvival Signaling and exerting Antifibrotic and Angiogenic Effects(Genetics/Genetically engineered models/Gene therapy(M),Oral Presentat
- OJ-254 Erythropoietin Drug Delivery System protects the heart against myocardial infarction through activation of Akt and angiogenesis(Growth factor/Cytokine-2(H/M), The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OE-128 Pioglitazone, an Anti-Diabetic Drug, Reduces Myocardial Infarct Size via Stimulating Peroxisome Proliferator Activated Receptor-γ (PPARγ) in Rabbits Model of Myocardial Infarction(Myocardial ischemia/reperfusion, basic/clinical-1, The 71st Annual S